Results 31 to 40 of about 5,643,282 (147)

Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as ...
Indranee Rajapreyar, MD, Joanna Joly, MD, Jose Tallaj, MD, Salpy V. Pamboukian, MD, Ayman Haj Assad, MD, Carrie Lenneman, MD, Silvio Litovsky, MD, Arka Chatterjee, MD, Charles Hoopes, MD, Andrew Lenneman, MD   +9 more
doaj   +1 more source

Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling [PDF]

, 2014
Grazia Daniela Femminella,1 Vincenzo Barrese,2,3 Nicola Ferrara,1,4 Giuseppe Rengo4 1Department of Translational Medical Sciences, Federico II University, Naples, Italy; 2Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II
Ferrara, N, Barrese V, Ferrara N, FERRARA, NICOLA, Rengo, G, Barrese, Vincenzo, FEMMINELLA, GRAZIA DANIELA, Femminella GD, Barrese, V, Rengo G, Femminella, GD, RENGO, GIUSEPPE   +11 more
core   +1 more source

Single Center Experience With Impella 5.5 for Escalation and De-Escalation of Cardiogenic Shock Patients

Journal of Interventional Cardiology
Temporary mechanical circulatory support (tMCS) devices are a critical component for treating patients with cardiogenic shock (CS). We analyzed use of Impella 5.5 device for efficacy and safety in a single-center CS population from February 2022 and ...
Ioana Dumitru, Debbie Rinde-Hoffman, Maria Sevillano, Leeandra Schnell, Elizabeth Quintilliani, Swaroop Bommareddi   +5 more
doaj   +1 more source

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure

Stem Cells International, 2018
Aim of the Review. The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods.
Gregor Poglajen, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Vesna Andročec, Matjaž Sever, Peter Černelč   +6 more
doaj   +1 more source

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy

Journal of Cardiovascular Development and Disease, 2022
Aims: Non-ischaemic dilated cardiomyopathy (NIDCM) is characterized by left ventricular (LV) chamber enlargement and systolic dysfunction in the absence of coronary artery disease.
Carles Díez-López, Joel Salazar-Mendiguchía, Elena García-Romero, Lara Fuentes, Josep Lupón, Antoni Bayés-Genis, Nicolás Manito, Marta de Antonio, Pedro Moliner, Elisabet Zamora, Pablo Catalá-Ruiz, Miguel Caínzos-Achirica, Josep Comín-Colet, José González-Costello   +13 more
doaj   +1 more source

MAD or MADness?

Cardiovascular Ultrasound
Mitral valve prolapse (MVP) is a common condition affecting approximately 3% of the population, typically with a benign clinical course. However, a small subset of patients (5–10%) may develop severe mitral regurgitation or arrhythmias, which can lead to
Francesco Fulvio Faletra, Giuseppe Sgarito, Francesca Parisi, Eluisa La Franca, Massimiliano Mulè, Alessandra Carvelli, Giovanni Di Stefano, Rita Laura Borrello, Vincenzo Nuzzi, Paolo Manca, Manlio Cipriani   +10 more
doaj   +1 more source

Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction

Journal of Cardiovascular Development and Disease
Background and aims: Vericiguat lowers cardiovascular death or heart-failure hospitalization in recently worsened heart failure with reduced ejection fraction (HFrEF), but its effects on cardiac remodeling are less well characterized.
Tine Bajec, Neža Žorž, Sabina Ugovšek, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Renata Okrajšek, Petra Girandon Sušanj, Miran Šebeštjen, Bojan Vrtovec, Gregor Poglajen   +10 more
doaj   +1 more source

Advanced Heart Failure [PDF]

Internal Medicine, 2019
Abstract Advanced heart failure (AHF) is the stage of heart failure (HF) refractory to maximal medical treatment, cardiac devices (CRT - cardiac resynchronization, ICD - implantable defibrillator) and surgical treatment. AHF has become of interest through the experience and favorable results of treatment by mechanical circulatory ...
openaire   +1 more source

Stress Testing in Heart Failure with Preserved Ejection Fraction

, 2021
Exertional dyspnea is the most common symptom in patients with heart failure with preserved ejection fraction; however, it is not specific to this disease.
심지영, Chi Young Shim
core   +1 more source

Prognostic Role of Pulmonary Arterial Capacitance in Advanced Heart Failure [PDF]

, 2012
Background—Right ventricular (RV) dysfunction frequently occurs and independently prognosticates in left-sided heart failure. It is not clear which RV afterload measure has the greatest impact on RV function and prognosis.
Taylor, David O., Tang, W.H. Wilson, Skouri, Hadi N., Starling, Randall C., Wu, Yuping, Abrahams, Zuheir, Dupont, Matthias, Mullens, Wilfried, Wu Y., Tang W.H.W., Mullens W., Taylor D.O., Skouri H.N., Dupont M., Starling R.C., Abrahams Z.   +15 more
core   +2 more sources